AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Protara Therapeutics, Inc. Director's Dealing 2017

Aug 4, 2017

34057_dirs_2017-08-04_ce5c304e-9339-49e5-87e2-2db82a9ca7f0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2017-08-02

Reporting Person: LEFF JONATHAN S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct